The Motley Fool
28 Jun 2026, 14:05 UTC · 2h ago
In a Volatile Market, This Dividend Growth Stock Is Worth Every Penny of $1,000
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
The Motley Fool
28 Jun 2026, 14:05 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
Abbott Laboratories (ABT) is trading at a forward P/E of 16.5, a discount compared to competitors like Johnson & Johnson which trade above 20. — Relative undervaluation compared to peers suggests potential for price appreciation to close the valuation gap.
+0.40Abbott Laboratories has a sustainable dividend payout ratio of 41.6%, remaining below the 50% threshold typically considered safe. — Low payout ratios indicate strong dividend security and room for future dividend increases, appealing to income investors.
+0.30Investors have expressed concern regarding Abbott's $21 billion acquisition of Exact Sciences, contributing to recent weak price action. — Large-scale acquisitions often introduce integration risks and short-term financial dilution that can weigh on stock price.
-0.30Continue reading
6 related stories
Search tags
Abbott Laboratories has increased its quarterly cash dividend for 55 consecutive years. — Dividend King status signals long-term financial stability and reliability, reducing risk for conservative investors.
+0.20Which stocks this story touches
The author explicitly recommends it as a 'name to buy and hold' due to its Dividend King status and sustainable payout ratio.
Mentioned only as a valuation benchmark for comparing forward earnings multiples.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
4h ago
